Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeharu Minamitani

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Virology|January 21, 2011
Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathwayTakeharu Minamitani, Dai Iwakiri, Kenzo Takada
Journal of Virology|May 24, 2013
Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activationDai Iwakiri, Takeharu Minamitani, Mrinal Samanta
Biological & Pharmaceutical Bulletin|November 7, 2002
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasionTakeharu Minamitani, Hiroyoshi Ariga, Ken-Ichi Matsumoto
Experimental Cell Research|June 15, 2004
Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagenTakeharu Minamitani, Hiroyoshi Ariga, Ken-ichi Matsumoto
Experimental Cell Research|June 24, 2004
Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathwayKen-Ichi Matsumoto, Takeharu Minamitani, Yasuko Orba, et al.
International Immunology|August 24, 2018
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1Chao-Yuan Tsai, Shuhei Sakakibara, Teruhito Yasui, et al.
Scientific Reports|November 17, 2021
Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device supportToshihiro Ito, Takeharu Minamitani, Masaki Hayakawa, et al.
Scientific Reports|June 10, 2021
Novel neutralizing human monoclonal antibodies against tetanus neurotoxinTakeharu Minamitani, Karin Kiyose, Ryota Otsubo, et al.
Transfusion|April 29, 2023
Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility studyRika A Furuta, Teruhito Yasui, Takeharu Minamitani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2015
Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2ATakeharu Minamitani, Teruhito Yasui, Yijie Ma, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Virology|January 21, 2011
Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathwayTakeharu Minamitani, Dai Iwakiri, Kenzo Takada
Journal of Virology|May 24, 2013
Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activationDai Iwakiri, Takeharu Minamitani, Mrinal Samanta
Biological & Pharmaceutical Bulletin|November 7, 2002
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasionTakeharu Minamitani, Hiroyoshi Ariga, Ken-Ichi Matsumoto
Experimental Cell Research|June 15, 2004
Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagenTakeharu Minamitani, Hiroyoshi Ariga, Ken-ichi Matsumoto
Experimental Cell Research|June 24, 2004
Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathwayKen-Ichi Matsumoto, Takeharu Minamitani, Yasuko Orba, et al.
International Immunology|August 24, 2018
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1Chao-Yuan Tsai, Shuhei Sakakibara, Teruhito Yasui, et al.
Scientific Reports|November 17, 2021
Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device supportToshihiro Ito, Takeharu Minamitani, Masaki Hayakawa, et al.
Scientific Reports|June 10, 2021
Novel neutralizing human monoclonal antibodies against tetanus neurotoxinTakeharu Minamitani, Karin Kiyose, Ryota Otsubo, et al.
Transfusion|April 29, 2023
Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility studyRika A Furuta, Teruhito Yasui, Takeharu Minamitani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2015
Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2ATakeharu Minamitani, Teruhito Yasui, Yijie Ma, et al.
Pageof 2